These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 10443258)

  • 1. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of Kell incompatibility in a 15-year retrospective study of mother-child serology in clinical records].
    Schönitzer D
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():3-9. PubMed ID: 3596796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Test for blood group incompatibility in pregnancy].
    Okubo M; Tate A; Maeda H; Suzuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():803-6. PubMed ID: 20942195
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    van der Does JA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2342. PubMed ID: 10589231
    [No Abstract]   [Full Text] [Related]  

  • 10. [Irregular blood group antagonisms].
    Heringa MP; Waelput AJ; Flikweert S
    Ned Tijdschr Geneeskd; 1999 Sep; 143(38):1933-4. PubMed ID: 10526625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of the Coombs-Bromeline test in ABO feto-maternal blood incompatibilities].
    Richon J; Streiff F; Genett B; Landes P; Brunel G; Raffoux C; Pierron N; Pétry JM; Schweitzer M
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(5):533-7. PubMed ID: 5510594
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of neonatal ABO immunization which was difficult to diagnose. The mother with blood group A2 and the infant with negative direct antiglobulin test].
    Kumlien G; Sarman I; Shanwell A
    Lakartidningen; 2000 Sep; 97(38):4138-40. PubMed ID: 11068380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the 's-Hertogenbosch].
    de Vrijer B; Harthoorn-Lasthuizen EJ; Oosterbaan HP
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2523-7. PubMed ID: 10627755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention, diagnosis and treatment of blood group immunization during pregnancy].
    van Aken WG; Christiaens GC
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2507-10. PubMed ID: 10627751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of antibodies in isoimmunization in pregnancy].
    Massi GB; Cirese E; Galati G; Sbiroli C
    Riv Ostet Ginecol; 1969 Jun; 24(6):201-7. PubMed ID: 4985252
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of irregular antibodies found in patients and in pregnancy tests].
    Busch H; Rothe B von E; Hochweller E
    Munch Med Wochenschr; 1970 Feb; 112(8):341-51. PubMed ID: 4997704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Systematic findings of irregular antibodies in pregnant women].
    Battaglini P; Bridonneau C
    Transfusion (Paris); 1967; 10(2):191-7. PubMed ID: 4965021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.